Co-Authors
This is a "connection" page, showing publications co-authored by BENJAMIN MUSHER and MALCOLM BRENNER.
Connection Strength
0.464
-
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. Nat Med. 2026 Jan; 32(1):258-269.
Score: 0.246
-
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500.
Score: 0.218